GlassScriptPhysician profile
Shelby Lim
NPI 1316602568
$6,542.37
in general payments reported to CMS, 2019-2025
37 companies · $3,140 in 2025
The $3,140 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,047 · 2024: $2,355 · 2025: $3,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,542.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $578.78 | 2024-2025 | Repatha, Repatha, Otezla |
| Gilead Sciences, INC. | $559.22 | 2023-2025 | Vemlidy, Yeztugo, Epclusa |
| Phathom Pharmaceuticals, INC. | $504.31 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $410.21 | 2023-2024 | Arexvy, Rotarix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $335.03 | 2024-2025 | Lokelma, Farxiga |
| Abbvie INC. | $295.96 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $285.63 | 2024-2025 | |
| Novo Nordisk INC | $273.11 | 2023-2025 | Wegovy, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $240.00 | 2023-2025 | |
| Lilly USA, LLC | $231.12 | 2023-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $217.30 | 2024-2025 | Assurity, Aveir, Gallant |
| Boston Scientific Corporation | $192.02 | 2025 | Watchman Flx, Mylux Patient Kit With Mobile Device |
| E.R. Squibb & Sons, L.L.C. | $188.09 | 2024-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $181.25 | 2023-2025 | Nexletol, Nexlizet |
| Edwards Lifesciences Corporation | $169.03 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.93 | 2024-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $143.05 | 2025 | Amvuttra |
| Ipsen Biopharmaceuticals, INC | $139.17 | 2024 | Iqirvo |
| Abiomed | $130.00 | 2024 | Impella |
| Teva Pharmaceuticals USA, INC. | $129.93 | 2024 | Austedo Xr |
| Antares Pharma, INC. | $129.32 | 2024 | Xyosted |
| Exact Sciences Corporation | $125.00 | 2025 | The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.88 | 2025 | Xifaxan |
| Corcept Therapeutics | $121.20 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $118.30 | 2023-2025 | Verquvo |
| Astellas Pharma US INC | $116.83 | 2023 | Veozah |
| Sanofi-Aventis U.S. LLC | $113.53 | 2025 | |
| Pfizer INC. | $60.82 | 2023-2024 | |
| Recor Medical INC | $52.90 | 2024-2025 | Paradise, Paradise Ultrasound Renal Denervation System |
| Regeneron Healthcare Solutions, INC. | $47.80 | 2025 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.17 | 2025 | Lifevest |
| Indivior INC. | $28.95 | 2023 | Perseris |
| Hologic Sales and Service, LLC | $24.22 | 2023 | Aptima |
| Otsuka America Pharmaceutical, INC. | $23.16 | 2023 | Abilify Maintena |
| Bridgebio Pharma, INC. | $20.69 | 2025 | Attruby |
| Baxter Healthcare | $19.19 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $17.27 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelby Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.